MMP9 and cancer: The angiogenic and invasive effects of PARVA-induced signalling in cancer cells might be attributed to the PI3K–Akt pathway rather than to the increase in NADPH expression, although the MMP9 level was elevated in these cells (Fig. 4A and 5A).